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Tissue kallikreins are a group of serine proteases that are
found in many organs and biologic £uids.Tissue kallik-
rein genes (KLKs) are found on chromosome 19q13.3^4 as
a gene cluster encoding 15 di¡erent serine proteases. In
skin, two tissue kallikrein proteins, hK5 and hK7, are
expressed in the stratum corneum and are known to be
involved in desquamation of corneocytes. The possible
involvement of other kallikrein proteins has not been
clari¢ed, however, nor has the signi¢cance of each
member in the serine protease activity of skin been de-
lineated. In the study described here, we examined ex-
pression and localization of KLK mRNA in normal
human skin by means of RT-PCR and in situ hybridiza-
tion. Quantitative RT-PCR analysis showed abundant
expression of KLK1 and KLK11 mRNA, moderate ex-
pression of KLK4, KLK5, KLK6, KLK7, and KLK13
mRNA, and low expression of KLK8 mRNA in nor-
mal human skin. For KLK4, KLK8, and KLK13
mRNA, splice variants were identi¢ed to be their major
mRNA species. Two variants for KLK13 mRNA were
novel. The amount of the serine protease inhibitor Ka-
zal-type 5 (SPINK5) mRNAwas comparable to KLK1
and KLK11 mRNA. In situ hybridization revealed in-
tense expression of all KLK mRNA studied except
KLK12 mRNA in the stratum granulosum of normal
epidermis, where SPINK5 mRNA coexisted. Excluding
KLK13 mRNA, they are also expressed in hair sheath,
eccrine sweat glands, and sebaceous glands. Coexpres-
sion of various KLK and SPINK5 mRNA suggests that
their proteins are the candidates to balance and main-
tain serine protease activities in both the skin and
appendages. Key words: desquamation/serine protease inhibi-
tor/stratum corneum chymotrypsin-like serine protease/stratum
corneum trypsin-like serine protease/tissue kallikrein. J Invest
Dermatol 121:542 ^549, 2003
T
he stratum corneum (SC) provides the outer layer of
the skin as a barrier against any kind of external sti-
muli including desiccation, entry of noxious chemi-
cals, and microbes. The proliferation of keratinocytes
to corneocytes is matched by the shedding of the old
corneocytes at the SC to maintain a constant number of corneo-
cyte layers or the integrity of this barrier function regardless of
age (Ya-Xian et al, 1999; Harding et al, 2000). In keratinocytes,
desmosomes are important epidermal adhesion complexes that
are characterized by a cell-speci¢c expression of transmembrane
cadherins and plaque-associated molecules. Two subfamilies of
desmosomal cadherins, desmocollin and desmoglein, form lateral
dimers and interact with dimers on neighboring cells. Intracellu-
larly, they can each bind to desmoplakin via plakoglobin or pla-
kophilin; namely desmosomal plaques and desmoplakin can bind
to the intermediate ¢lament network (Angst et al, 2001). Desmo-
somes are subjected to not only morphologic (Skerrow et al, 1989;
Serre et al, 1991), but also compositional (Knaggs et al, 1994)
transformation into corneodesmosomes at the stratum granu-
losumSC interface (Menon et al, 1992). Extracellular (corneo-
desmosin) and transmembrane (desmoglein-1 and desmocollin-
1) corneodesmosomal proteins, as well as cytoplasmic desmoso-
mal plaque proteins (plakoglobin), are all degraded in the upper
SC (Simon et al, 2001a). Degradation of corneodesmosomes
abolishes corneocyte attachment causing the desquamation of
corneocytes (Chapman andWalsh, 1990; Lundstrom and Egelrud,
1990;Vicanova et al, 1996).
For the degradation of these adhesion molecules, the activity
of both trypsin-like and chymotrypsin-like serine proteases is in-
dispensable (Suzuki et al, 1996; Ekholm et al, 2000). Recently, two
serine proteases were isolated and cloned from skin tissue. At
¢rst, trypsin-like or chymotrypsin-like serine protease activities
in the skin were considered to be dependent on these two pro-
teases alone and so they were designated, respectively, the stratum
corneum trypsin-like enzyme (SCTE) (Brattsand and Egelrud,
1999) and the stratum corneum chymotrypsin-like enzyme
(SCCE) (Hansson et al, 1994). Later, these two enzymes were
found to be members of the tissue kallikrein gene (KLK) family.
This family consists of genes encoding for 15 di¡erent secreted
serine proteases, all of which are localized on chromosome
19q13.3^4 as a cluster (Yousef and Diamandis, 2001). According
to the o⁄cial tissue kallikrein nomenclature, SCTE and SCCE
genes have been renamed KLK5 and KLK7, respectively, and
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their proteins as hK5 and hK7 (Diamandis et al, 2000). Although
hK5 and hK7 preferentially degrade corneodesmosin, they do not
degrade desmoglein-1, another major transmembrane component
of corneodesmosomes (Simon et al, 2001b). As the whole extract
of stratum corneum serine protease activity degrades desmoglein-
1 (Suzuki et al, 1996), it is conceivable that there must be other
serine proteases aside from hK5 and hK7 that play important
roles in the degradation of corneodesmosomes and desquamation
of corneocytes. Other members of the hKs could also be compo-
nents of the SC serine protease activity. Their possible involve-
ment has not been clari¢ed, however, nor the signi¢cance of
each hK in the serine protease activity of skin. Here, we study
the di¡erential expression of each KLK mRNA in normal skin
and cultured normal human epidermal keratinocyte (NHEK)
cells by means of quantitative RT-PCR.We also demonstrate by
in situ hybridization the KLK mRNA regional expression in epi-
dermis and appendages, compared to that of the serine protease
inhibitor Kazal-type 5 (SPINK5) mRNA (Magert et al, 1999).
SPINK5 mRNA is expressed in the uppermost skin epidermis
(Komatsu et al, 2002a) and is supposed to be important for inhi-
bitory regulation of SC serine protease activity. Its genetic defect
could manifest clinical features with over-desquamation, an aber-
rant hair growth, and temperature instability by an inappropriate
sweat and sebum secretion known as Netherton syndrome (Grif-
¢ths et al, 1998; Chavanas et al, 2000; Komatsu et al, 2002a).
MATERIALS AND METHODS
Human keratinocyte culture Normal human keratinocytes
(Epidercell NHEK [F], Kurabo, Osaka, Japan) were inoculated at a
concentration of 2500 cells per cm2 in HuMedia-KG (Kurabo) containing
10 mg per ml insulin, 0.1 ng per ml human recombinant epidermal growth
factor, 0.5 mg per ml hydrocortisone, 50 mg per ml gentamicin, 50 ng per
ml amphotericin B, and 0.4% vol/vol bovine pituitary extract. The calcium
concentration of the medium was as low as 0.15 mM in order to avoid
di¡erentiation. The culture was maintained at 371C in a 95% O2/5% CO2
humidi¢ed chamber. The cells were subcultured twice when they became
60%^80% con£uent.
Samples from normal human skin Normal human skin samples were
obtained from the curative resection of nine patients (¢ve females and four
males, 5179 y old, mean7SD). The resection was performed on portions
at least 2 cm from the edge of histologically diagnosed benign skin tumors
located in either extremities or trunk, such as nonin£amatory epidermal
cysts and seborrheic keratosis. Five samples were utilized for RT-PCR
and four for in situ hybridization. All of the patients gave informed
consent at Kanazawa University Hospital during 1997^2000.
RT-PCR detection of KLK and SPINK5 mRNA in normal human
skin and cultured human keratinocytes Total RNAwas isolated from
NHEK [F] and normal human skin with the guanidinium/isothiocyanate
phenol/chloroform extraction method. Single-stranded cDNA was
synthesized in a total volume of 20 mL containing 2 mg of total RNA,
0.5 mM of oligo-dT as a primer, the reverse transcription bu¡er, 2 mM
of dNTPs, 50 U of RevatraAse reverse transcriptase (Toyobo, Osaka,
Japan), and 20 U RNase inhibitor (Toyobo). One microliter aliquot was
subjected to PCR ampli¢cation targeting glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) ampli¢cation in order to normalize the amount
of reverse-transcribed cDNA. PCR ampli¢cation was also performed
using oligonucleotide primers targeting KLK1, KLK4, KLK5, KLK6,
KLK7, KLK8, KLK9, KLK10, KLK11, KLK12, KLK13, and KLK14 mRNA
(GenBank Accession nos. AF243527, NM002257 (KLK1), XM 031805
(KLK4), NM 012427 (KLK5), NM 002774 (KLK6), NM 005046 (KLK7),
NM 144505 (KLK8), XM 064846 (KLK9), AF 024605 (KLK10), BC
022068 (KLK11), NM 019598 (KLK12), NM 015596 (KLK13), AF283670
(KLK14), and SPINK5 (NM 006846)). Primer sequences and conditions
are described in Table I and locations in Fig 1. Primers for KLK1, KLK4,
KLK10, KLK11, KLK13, and KLK14 mRNA are described elsewhere
(Harvey et al, 2000; Yousef et al, 2000). No expression of KLK2 and KLK3
mRNA has been con¢rmed in skin; hence they were not included in this
study (Gan et al, 2000; Harvey et al, 2000). The ampli¢ed DNA samples
were separated on 1%^1.5% low-melting agarose gel and were visualized
with ethidium bromide. When aberrant bands suggesting alternative
splicing were ampli¢ed, electrophoreses were performed until each band
Table I. Primer sequence
mRNA Primers Annealing temperature (1C) Product lengtha (b)
KLK1b Forward 50 -TGGAGAACCACACCCGCCAAG-30 61 428
Reverse 50 -ACGGCGACAGAAGGCTTATTG-30
KLK4b Forward 50 -GCGGCACTGGTCATGGAAAAGG-30 61 526
Reverse 50 -CAAGGCCCTGCAAGTACCCG-30
KLK5 Forward 50 -AGCAGCAGCCGCATCATCAAT-30 61 575
Reverse 50 -GCGCAGAACATGGTGTCATCT-30
KLK6 Forward 50 -AAGGGAGAGTTCCCAGGAGCA-30 61 774
Reverse 50 -GGGGAGAGGAGATGCCTAGAA-30
KLK7 Forward 50 -AATGAGTACACCGTGCACCTG-30 61 484
Reverse 50 -AGACTCCTGGGTCATTGGGTT-30
KLK8 Forward 50 -TCTGGAAGACCTCACCATGGG-30 61 761
Reverse 50 -CAGGTAGCGGCAGATGTTGGT30
KLK9 Forward 50 -TCATGAAGCTGGGACTCCTCT-30 61 892
Reverse 50 -AGGGGCGGAGCTATTTTGTGT-30
KLK10b Forward 50 -GCGGAAACAAGCCACTGTGGG-30 61 486
Reverse 50 -GGTAAACACCCCACGAGAGGA-30
KLK11b Forward 50 -CCGCTACATAGTTCACCTGG-30 61 284
Reverse 50 -AGGTGTGAGGCAGGCGTAACT-30
KLK12 Forward 50 -TTGACCACAGGTGGGTCCTCA-30 61 542
Reverse 50 -GTGTAGACTCCAGGGATGCCA-30
KLK13c Forward 50 -CTAGTGATCGCCTCCCTGAC-30 61 819
Reverse 50 -TTATTGTGGGCCCTTCAACC-30
KLK14b Forward 50 -CTGGGCAAGCACAACCTGAG-30 58 517
Reverse 50 -GCATCGTTTCCTCAATCCAGC-30
SPINK5 Forward 50 -ACTCGAGAAAGTGACCCTGTC-30 61 263
Reverse 50 -TTGCCATATGGGCCTCGAACA-30
aPredicted product length of classical form.
bReferred from Harvey et al (2000).
cReferred fromYousef et al (2000).
THE EXPRESSION OF KLK mRNAs IN SKIN 543VOL. 121, NO. 3 SEPTEMBER 2003
was at least 3 mm apart. After excision, each band was dissolved at 651C,
washed with phenol/chloroform, and ethanol-precipitated. The products
obtained were subjected to bidirectional direct sequence analysis using the
same primers used for PCR ampli¢cation.
For quantitative comparison, the samples were separated on a 1%
agarose/ethidium bromide gel and the intensity of each band was obtained
by densitometric scanning and measured with a Macintosh computer G3
using the public domain NIH Image program (written byWayne Rasband
at the US National Institute of Health and available from the Internet by
anonymous ftp from zippy.nimh.nih.gov) (Fig 2 and Table II). After
con¢rming the cycles and the concentrations of templates required for
exponential ampli¢cation of GAPDH (Fig 2), each template was diluted
to show half-maximal ampli¢cation of GAPDH at 22 cycles. Such a
procedure con¢rmed the usage of the same amount of cDNA in terms
of GAPDH expression. Thereafter, cycles required for exponential
ampli¢cation for each object mRNAwere examined. The amount of each
mRNAwas calculated by comparing the cycles required for half-maximal
ampli¢cation over GAPDH expression (Fujii et al, 1998).
In situ hybridization for KLK and SPINK5 mRNAs in normal
human skin The bidirectional cRNA probes for KLK1, KLK4, KLK6,
KLK8, KLK9, KLK10, KLK11, KLK12, KLK13, KLK14, and SPINK5
mRNAs were synthesized from IMAGE Consortium clones (cDNA-Ids,
respectively, 2470227, 2321042, 740000, 2306163, 1088637, 2070689, 740780,
4227367, 1644236, 2465019, and 358027; Research Genetics, Livermore,
CA) using either T7, T3, or SP6 RNA polymerase (Takara, Tokyo, Japan)
and the DIG Labeling Kit (Boehringer, Mannheim, Germany). These
clones included cDNA inserts ranging from 218 to 566 bp in length (Fig 1).
Their sequence was complementary to the 30 untranslated region and/or the
30 terminus of the coding region, having less than 10% homology with
each other. The e⁄cacy of DIG incorporation to each cRNA was
con¢rmed to be approximately the same. The formalin-¢xed para⁄n-
embedded specimens of normal human skin were cut into 5 mm sections
and mounted on silane-coated glass slides. The sections were treated with
10 mg per ml Proteinase K (Sigma, St Louis, MO) at 371C for 30 min,
treated with 0.2 M HCl, acetylated with 0.25% acetic anhydride in 0.1 M
triethanolamine, pH 8.0, dehydrated with ethanol series, and air dried.
After prehybridization with the hybridization solution containing 50%
formamide, 10% dextran sulfate, 1Denhardt’s solution (Maniatis et al,
1989), 600 mM NaCl, 0.25% sodium dodecyl sulfate, and 150 mg per ml
yeast tRNA at 501C for 2 h, each slide was allowed to hybridize with
approximately 0.5 mg per ml of the cRNA probe at 501C overnight. The
slides were washed brie£y in 5 sodium citrate/chloride bu¡er (SSC) at
ambient temperature in 50% formamide and in 2 SSC at 501C for 30
min, treated with 10 mg per ml RNase A at 371C for 30 min, and again
washed once with 2 SSC and twice with 0.2 SSC for 20 min each at
501C. Hybridized probes were detected with the Nucleic Acid Detection
Kit (Boehringer). Negative control staining was carried out using cRNA
with sense direction as probes. For quantitative comparison, intensity of
hybridization in each area over background staining was measured using
the public domain NIH Image program as described above.
Statistical analysis for RT-PCR and in situ hybridization
Di¡erences of the cycles required in normal skin were compared using
one-way ANOVA following Fisher’s PLSD as a post hoc test. Thereafter,
the amounts of KLK mRNA were estimated over GAPDH mRNA
expression. In in situ hybridization, the intensities for each KLK mRNA
were compared using Friedman’s analysis. The statistical package used was
Statview v.5 (Japanese version, SAS Institute, Cary, NC).
Figure1. Schematic diagram of the structure of KLKs. The KLK
whose slicing variants (a) were not detected and (b) were detected by RT-
PCR, and (c) the genes whose mRNA could not be detected by either RT-
PCR or in situ hybridization. All genes consist of ¢ve coding exons of si-
milar lengths (open boxes where exon lengths are indicated in bold letters)
(Yousef and Diamandis, 2001). The open boxes with normal font numbers
represent the exon length indicating either 50 or 30noncoding regions,
whereas lines indicate introns. The location of start and stop codons are in-
dicated, respectively, by the triangle and asterisk. Histidine (H), aspartic acid
(D), and serine (S) represent the conserved catalytic triad of serine pro-
teases. The circled D, asparagine (N), and glycine (G) in exon 4 indicate
the binding pocket that is crucial for substrate speci¢city, respectively, for
trypsin-like activity of hK1, hK4, hK5, hK6, hK8, hK11, hK13, and hK14
and the chymotrypsin-like activity of hK7 and hK9. Underlining indicates
the location of the cRNA probe synthesized using IMAGE clones. Horizon-
tal arrows indicate the approximate locations of primers whose sequences are
listed in Table I. Multiple bands were obtained when the sets of primers
targeting KLK4, KLK8, and KLK13 cDNAwere used, as shown in Fig 3.
The schema of their alternative splicings is shown using solid black boxes be-
low the classical forms, according to the sequence analysis shown in Fig 4.
The variant KLK4-2 mRNA skipped from the end of exon 3 to the begin-
ning of exon 5 so that its deduced amino acids lacked S in a conserved
catalytic triad and caused a frameshift resulting in a premature stop codon
(). The KLK8 type 3 mRNA lacked coding for exons 2 and 3 without
amino acid frameshift, and the type 4, lacking coding exons 2^4, resulted
in an amino acid frameshift similar to KLK4-2 mRNA. In addition to loss
of H and D in the triad, the putative proteins of KLK8 type 3 and type 4
mRNAs are unlikely to be secreted, because they possess incomplete secre-
tory signal peptides (Magklara et al, 2001). Moreover, KLK8 type 4 mRNA
lacked D on exon 4, which is essential for tryptic activity (Yousef and Dia-
mandis, 2001). KLK13-2 and KLK13-3 mRNAs lacked, respectively, D, and
H and D in the triad but maintained their frames. , frameshifts result in
amino acid substitutions and premature stop codon.
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RESULTS
Expression of KLK1, KLK4, KLK5, KLK6, KLK7, KLK8,
KLK11, KLK13, KLK14, and SPINK5 mRNAs in normal
human skin and cultured keratinocytes RT-PCR was
performed to amplify KLK1, KLK4, KLK5, KLK6, KLK7,
KLK8, KLK9, KLK10, KLK11, KLK12, KLK13, KLK14, and
SPINK5 mRNAs using sets of primers that were located on
coding or noncoding exons (Fig 1, Table I). Preliminary
experiments con¢rmed that each set of primers, excluding
KLK9, KLK10, and KLK12 mRNAs, was able to mediate
exponential ampli¢cation (Fig 3). Cycles providing half-
maximal ampli¢cation in RNA from NHEK cells ranged from
37 to 43. Unfortunately, the specimen was very small so that ¢ve
out of nine samples were used for RT-PCR and four were
reserved for in situ hybridization, and each of these samples was
analyzed separately but not pooled. No di¡erence in the pattern
of aberrant bands of KLK4, KLK8, and KLK13 mRNAs
ampli¢cation was observed within these ¢ve samples.
In normal skin, expression of KLK6 mRNAs was almost the
same as that of KLK5 and KLK7 mRNAs. KLK1 and KLK11
mRNAs were estimated to be more than ¢ve times as much as
these mRNAs. In the case of SPINK5 mRNA, the cycles
required for half-maximal ampli¢cation were not signi¢cantly
di¡erent from those of KLK1 and KLK11 mRNAs. Their
expression level in normal skin was almost the same as that in
NHEK, judging from the intensity of the band. The amount of
KLK14 mRNAs in NHEK cells was approximately a quarter of
KLK5 and KLK7 mRNAs and no band was visible after 42 cycles
of ampli¢cation in the skin (Fig 3, left).We could not detect any
bands for KLK9, KLK10, or KLK12 mRNAs with the set of
primers used (data not shown). Several aberrant bands,
suggestive of alternative splicing for KLK4, KLK8, and KLK13
mRNAs, were obtained either in NHEK or in the skin (Fig 3,
right). Although both KLK4-1 and KLK4-2 mRNA were
ampli¢ed in the skin, the major mRNA species was found to be
KLK4-2 mRNAs and its amount was almost the same as KLK5,
KLK6, and KLK7 mRNA. Regarding KLK8 and KLK13
mRNAs, variants alone were ampli¢ed in the skin. The amount
of KLK13 mRNA variant was comparable to those of KLK4-2,
KLK5, KLK6, and KLK7 mRNAs but that of KLK8 variant
mRNAwas approximately one-fourth. In order to con¢rm that
these variants were derived due to alternative splicing, their
sequences were analyzed.
Structure of splice variants for KLK4, KLK8, and KLK13
mRNAs By direct sequencing, all of the products were
con¢rmed to conserve the GT-AG rule (Breathnach et al, 1978)
(Figs 1b, 3, right, and Fig 4).
The primer set for KLK4 mRNAyielded two bands. Sequence
analysis con¢rmed that the larger product (approximately 530 bp)
corresponded to classical KLK4 (KLK4-1) mRNA containing all
exons. The smaller product (approximately 400 bp) was shown
to be a splice variant (KLK4-2 mRNA) skipping exon 4. The
amount of KLK4-2 mRNAwas slightly higher (approximately
10% in density) than that of KLK4-1 mRNA in NHEK cells,
whereas the major RNA species in normal human skin
appeared to be KLK4-2 mRNA. The skipping of exon 4 would
produce a predicted truncated protein due to frameshift and a
premature termination codon, causing lack of the serine residue
Figure 2. Representative ampli¢cation pro¢le for GAPDH and
KLK7 mRNAs by RT-PCR. (a) Relationship between intensities of
bands and the PCR cycles; 1 mL aliquot of reverse transcriptase mix from
skin tissue was used as a template. (b) Relationship between intensities of
bands and the dose of template; at 22 for GAPDH and 38 cycles of ampli-
¢cation. (c) The intensities and the cycles were plotted in order to con¢rm
exponential ampli¢cation. Solid circle, GAPDH mRNA; solid square, KLK7
mRNA. The products were separated on 1% agarose ethidium bromide
gels and the intensities of each band were quantitated. The amount of
cDNA was normalized by GAPDH ampli¢cation. The amount of each
KLK mRNAwas quanti¢ed by comparing each exponential ampli¢cation
curve. The cycles required for exponential ampli¢cation were con¢rmed
for all sets of primers and those for half of the maximal ampli¢cation are
indicated inTable II.
Table II. Di¡erences in the amounts of each KLK mRNA in
normal skin measured by cycles required for half-maximal
RT-PCR ampli¢cation
mRNA
Cycles required
for half-maximal
ampli¢cation
(mean7SE; n¼ 5)
Estimated amounts
over GAPDH
expression (106 of
GAPDH mRNA)
KLK1 36.970.3 66.8
KLK4-2 39.670.4 10.1
KLK5 39.570.3 10.8
KLK6 39.570.3 10.5
KLK7 38.870.3 17.1
KLK8 type 4 41.770.2 2.4
KLK11 36.970.2 65.6
KLK13-3 39.770.3 9.7
SPINK5 37.870.2 36.0
Signi¢cant di¡erences (one-way ANOVA and Fisher’s PLSD as a post hoc test,
po0.05): KLK1 vs KLK4-2, KLK5, KLK6, KLK7, KLK8 type 4, and KLK13-3;
KLK4-2 vs KLK8 type 4, KLK11, and SPINK5; KLK5 vs KLK8 type 4, KLK11,
and SPINK5; KLK6 vs KLK8 type 4.
Figure 3. Expression of KLK1, KLK4, KLK5, KLK6, KLK7, KLK8,
KLK11, KLK13, KLK14, and SPINK5 mRNA in normal human
skin and cultured keratinocytes. Products obtained by RT-PCR using
the sets of primers listed inTable I from normal human skin and cultured
keratinocytes. Left panels: KLK mRNAwithout alternative splicing. Right
panels: KLK mRNAwith alternative splicings. A 100 bp ladder was used as
a marker. Cycles indicate those required for ampli¢cation where the inten-
sity of bands (when aberrant bands were observed: 4-1 for KLK4 mRNA,
type 3 for KLK 8 mRNA, and 13-2 for KLK13 mRNA) was almost half of
the maximal ampli¢cation when 1 mL aliquot of NHEK reverse transcrip-
tase mixture was used as a template. The bands from normal skin were ob-
tained at the cycles indicated, and the volume of reverse transcriptase
mixture was adjusted in order to use the same amount of cDNA as
a template.
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that is required for protease activity (Fig 1b) (Myers and
Clements, 2001).
For KLK8 mRNA, we detected the splice variants known as
KLK8 type 3 and type 4 mRNA (GenBank Accession no.
AF251125) (Magklara et al, 2001) in both NHEK cells and
normal human skin (Figs 1b, 3, right, and Fig 4). Type 3
sequence joins exon 1 with exon 4, keeping the amino acid
frame, and type 4 joins exon 1 and exon 5, resulting in an amino
acid frameshift with premature termination (Fig 1b).The putative
proteins encoded by these two variants lack exon 2 and possess
incomplete secretory signal peptides; hence they are unlikely to
be secreted (Magklara et al, 2001). In contrast to almost the same
amount of expression in NHEK cells, type 4 was the major
mRNA species in normal skin.
There are at least four bands between 350 and 650 bp in size
and a faint band around 800 bp for KLK13 mRNA
ampli¢cation (Figs 1b, 3, right). From the approximately 650 bp
products, in addition to the 214 b-shorter alternative splicing
variant (GenBank Accession no. AF135024) (Yousef et al, 2000), a
novel splice variant lacking 219 b was isolated (Figs 1b, 4).
Although these two products could not be separated on agarose
gel, the major mRNA species is considered to be 219 b-shorter,
judging from the pattern of direct sequencing analysis. The
absence of the 219 bp sequence did not cause a frameshift, and
so this variant was considered to be a major splice variant in
NHEK cells and designated as KLK13-2 mRNA. The 30 exon
boundary of KLK13-2 mRNAwas encrypted inside exon 3 but
had a conserved GT donor consensus sequence. Such splicing
created an mRNA that is 219 bp shorter than classical KLK13
mRNA. Its deduced amino acid sequence provides a peptide
that is 73 amino acids shorter than classical KLK13 mRNA
(Figs 1b, 4). From the approximately 350 bp products, the
variant KLK13-3 mRNA lacking exons 2 and 3 was obtained.
This variant also had no frameshift, and its deduced amino acid
sequence is predicted to be 152 amino acids shorter than the
classical KLK13 mRNA. KLK13-2 mRNA lacked an aspartic
acid residue encoded by exon 3, an indispensable amino acid for
catalytic activity. Because of this, it is unlikely that KLK13-2
mRNAwill maintain protease activity. KLK13-3 mRNA lacked
the catalytic histidine residue in exon 2 as well as a part of the
signal peptide (Fig 1b) (Yousef et al, 2000). Thus, both variant
products are expected to have no enzymatic activity, and
furthermore KLK13-3 mRNA would not even be secreted. In
addition to an approximately 800 bp product possibly
corresponding to classical KLK13 mRNA, products between
450 and 500 bp in size, ampli¢ed from NEHK cells, could not
be cloned or sequenced. It is still unclear whether NEHK cells
expressed classical KLK13 mRNA but the splice variant KLK13-
3 mRNAwas the major mRNA species in normal skin.
Regional expression of KLK and SPINK5 mRNAs in
normal human skin Due to the high homology in the
coding regions of KLKs, we used cRNA probes complementary
to the 30 untranslated region and/or the 30 terminus of the coding
region that display low homology to each other (Fig 1). The
probes did not distinguish splicing variants. Our in situ
hybridization study demonstrated that a number of KLK
mRNAs, including KLK9, KLK10, and KLK14 mRNAs (Fig 5
and Table III) whose expression could not be detected by RT-
PCR, were expressed in human epidermis where hK5 and hK7
were found to be localized by immunohistochemistry (Ekholm
et al, 2000).
Prominent expression of all KLK mRNA studied (KLK1,
KLK4, KLK6, KLK9, KLK10, KLK11, KLK13, and KLK14
mRNA) was observed in the stratum granulosum of normal
epidermis (Fig 5a, Table III). In addition, di¡use hybridization
throughout the strata spinosum and basale was observed for
KLK1, KLK4, and KLK11 mRNAs. KLK10 mRNAwas positive
in the stratum spinosum but faint in the stratum basale. Faint
hybridization was observed for KLK6, KLK13, KLK14, and
SPINK5 mRNAs in both layers, whereas hybridization for
KLK9 mRNAs alone was negative (Table II). No positive
hybridization for KLK8 and KLK12 cRNA was apparent (data
not shown). SPINK5 mRNA expression was also localized to
the stratum granulosum and uppermost layer of the stratum
spinosum.
In appendageal structures (Fig 5bd,Table III), hybridization
for KLK1, KLK4, KLK6, KLK9, KLK10, KLK11, and KLK14 as
well as SPINK5 mRNAs was predominantly localized to the
inner root sheath of hair follicular epithelium but faint in the
outer root sheath (Fig 5b,Table III). KLK13 mRNAwere only
faintly apparent throughout hair follicular epithelium. In
sebaceous glands (Fig 5c, Table III), intense hybridization for
KLK4, KLK6, KLK9, KLK10, KLK11, and SPINK5 mRNAs
was observed not only in the cytoplasm of outer layer cells but
also in the thin cytoplasm compressed by lipid droplets of
mature cells, located in the center of the glands. It seemed that
the expression of KLK4, KLK9, KLK10, and SPINK5 mRNAs
was higher in basal layer undi¡erentiated sebocytes, however,
than in the centrally located lipid-accumulating mature
sebocytes even when the compression of cytoplasm was taken
into account. Hybridization of KLK1 and KLK14 mRNA was
low. Di¡use hybridization in the cytoplasm of eccrine sweat
glands (Fig 5d, Table III) was observed for KLK1, KLK4,
KLK6, KLK11, and KLK14, as well as for SPINK5 mRNAs. On
the other hand, hybridization of KLK9 and KLK10 mRNAwas
intense along the inner lumen. Such localization was similar to
that of SPINK5 mRNA. Very faint hybridization for KLK13
mRNA was observed in both eccrine sweat glands and
sebaceous glands. KLK8 and KLK12 mRNAs hybridization was
not observed in any appendageal structures (data not shown).
Figure 4. Sequence analysis for KLK cDNA with alternative spli-
cing. Numbers indicate the location of the bases of the boundary when
the A of the start codon is numbered 1. All exon^intron boundaries con-
served the classical GT-AG donor^acceptor consensus sequence. KLK4-1
mRNA represents cDNAwithout alternative splicing so that no base was
lacking. A splice variant (KLK4-2 mRNA) was consistent with that pre-
viously reported (Myers and Clements, 2001). For KLK8 mRNA, we de-
tected two splice variants in both NHEK and skin tissue (Fig 3). The
sequences of these variants were the same as KLK8 type 3 and type 4
mRNAs (GenBank Accession no. AF251125) (Magklara et al, 2001). For
KLK13 mRNA, the sequences of KLK13-2 and KLK13-3 mRNAs, respec-
tively, lacking 219 b and 456 b, were con¢rmed. From the approximately
650 bp products, in addition to KLK13-2 mRNA, the 214 b-shorter alter-
native splicing variant (GenBank Accession no. AF135024) (Yousef et al,
2000) was also isolated. The major mRNA species is considered to be 219
b-shorter, judging from direct sequencing analysis, and so this variant was
designated as KLK13-2 mRNA.
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Figure 5. In situ hybridization of KLK and SPINK5 mRNA in normal human skin. (a) Normal epidermis; (b) hair follicular epithelium; (c) sebac-
eous glands; (d) eccrine sweat glands. Scale bars indicate 50 mm for (a) and 100 mm for (b)^(d).The bidirectional cRNA probes for KLK1, KLK4, KLK6, KLK9,
KLK10, KLK11, KLK13, KLK14, and SPINK5 mRNAs synthesized from IMAGE Consortium clones were used as probes. Although sense cRNAs were
always served as negative control, only representative data using KLK13 sense cRNAs as a probe are indicated for each panel because hybridization for
antisense KLK13 cRNA was the faintest in all the structures. Among KLK mRNA with splicing variants, KLK4 and KLK13 mRNA seemed to have
su⁄cient length of 30 untranslated sequence for cRNA probe to hybridize, whereas KLK8 mRNA had only 45 b of 30 untranslated sequence and lacked
exons 3^5 for its cRNA probe to hybridize.
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DISCUSSION
Aside from KLK5 and KLK7 mRNA, we con¢rmed the expres-
sion of KLK1, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9,
KLK10, KLK11, KLK13, and KLK14 mRNAs in normal human
skin, either by RT-PCR or by in situ hybridization. Furthermore,
we report the existence of two novel splice variants for KLK13
mRNA in the skin as well as of several splice variants that have
been previously identi¢ed in other organs (Magklara et al, 2001;
Myers and Clements, 2001).
By means of quantitative RT-PCR, the predominant expres-
sion of KLK1 and KLK11 mRNAs was con¢rmed both in nor-
mal skin and in NHEK cells, an expression comparable with
SPINK5 mRNA. Expression of KLK5, KLK6, and KLK7
mRNAs was also con¢rmed but their levels were lower than
those of KLK1 and KLK11 mRNAs. For KLK4, KLK8, and
KLK13 mRNA, their splice variants seemed to be the major
mRNA species. Although the amounts of KLK4-2 and KLK13-
3 mRNAs were comparable to those of KLK5, KLK6, and KLK7
mRNA, KLK8 type 3 mRNAwas scarce. Moreover, regional ex-
pression of KLK8 mRNA could not be identi¢ed by in situ hy-
bridization. Probably due to lack of exons 3^5 in type 4 KLK8
mRNA, no hybridization could be detected. In any case, as the
major mRNA species detected for KLK8 mRNA were alterna-
tive splice variants that had no complete signal peptides, hK8
function may not be important in the skin. Although KLK9,
KLK10, and KLK12 mRNAs in both NHEK and skin tissue were
not ampli¢ed by RT-PCR, KLK9 and KLK10, but not KLK12,
mRNAs expression in skin tissue was detected by means of in situ
hybridization. A similar expression pattern for KLK9 mRNAwas
reported previously (Gan et al, 2000; Harvey et al, 2000). Expres-
sion of KLK14 mRNAs was faint even in the NHEK cells, so that
RT-PCR did not always con¢rm its expression in the skin. Its
expression was also con¢rmed by in situ hybridization, however.
Very limited localization of KLK9, KLK10, and KLK14 mRNAs
in the stratum granulosum may make their RT-PCR ampli¢ca-
tion di⁄cult. Judging from the fact that both RT-PCR and in situ
hybridization failed to con¢rm KLK12 mRNA expression,
KLK12 mRNA seems not to be expressed in normal skin.
As hK5 and hK7 preferentially degrade corneodesmosin but
not desmoglein-1 (Simon et al, 2001b), the involvement of other
serine proteases is likely, in order to complete desquamation. Re-
gional expression of KLK1, KLK4, KLK6, KLK9, KLK10, KLK11,
KLK13, and KLK14 mRNAs showed similar localization to hK5
and hK7 (Ekholm et al, 2000) in normal epidermis. Most of the
pro-form-hK would be activated by cleavage at either arginine
(R) or lysine (K) residues, and hKs may potentially act as activat-
ing enzymes for either themselves (autoactivation) or other pro-
form-hK (Yousef and Diamandis, 2001). Thus, hKs could act as
pleiotropic proteases for proteolytic processing of various precur-
sor proteins. Hence, regionally di¡erential expression of various
KLK mRNA suggests that their proteins are new potential can-
didates for the SC serine protease activities and may play an im-
portant role in the degradation of corneodesmosomes and in
desquamation of corneocytes. The simultaneous expression of
SPINK5 mRNA with these mRNA also suggests that serine
protease activity in the stratum granulosum is regulated by the
balance of hK and inhibitory polypeptides derived from
SPINK5.
In hair follicles, KLK1, KLK4, KLK6, KLK9, KLK10, KLK11,
and KLK14 mRNAs were expressed more intensely in the inner
hair sheath than in the outer hair sheath. hK7 is reportedly
expressed both in the inner hair sheath and in the outer hair
sheath (Ekholm and Egelrud, 1998). Mouse neuropsin, a mouse
homolog of hK8, is expressed in the deeply eosinophilic kerati-
nizing zone of the hair cortex and inner root sheath (Inoue et al,
1998). In the human, however, hK8 function may not be impor-
tant because it is considered that hK8 in the skin lacks a signal
peptide as described above and no signi¢cant hybridization was
observed by in situ hybridization.The outer hair sheath is a down-
ward extension of the epidermis, whereas both the hair and the
inner root sheath are originated from the pluripotential cells of
the hair matrix. The hair cuticles are tightly interlocked with the
cells of the inner root sheath cuticle so that the hair and the inner
root sheath move upward in unison (Murphy, 1997). In the case of
Netherton syndrome where serine protease inhibitor activities of
SPINK5-derived peptides are lacking, hair shaft defects are ob-
served (Gri⁄ths et al, 1998). Topical trypsin treatment following
depletion induces a delay in hair growth (Seiberg et al, 1997).
Moreover, the soybean-derived serine protease inhibitors a¡ect
the rate of hair growth, the dimensions of the hair follicle and
hair shaft, and the appearance of the hair (Seiberg et al, 2001). It
is likely that the maintenance of serine protease activity balanced
by hKs and SPINK5-derived peptides in the inner root sheath is
important for hair growth. On the other hand, the inner root
sheath degraded at the level where the sebaceous duct enters
the hair follicle, the hK activities in the outer root sheath may
directly act on hair in the infundibulum. Similarly, the hK activ-
ities in the outer root sheath seem important in the involution of
hair follicle from anagen phase into catagen phase because the in-
ner root sheath usually totally disappears but a part of the outer
root sheath remains permanent. For maturation and/or holocrine
or sebaceous glands, coexpression of KLK4, KLK6, KLK9,
KLK10, KLK11, and SPINK5 mRNAs suggests that the balance
of their products is important. High expression in KLK4, KLK9,
KLK10, and SPINK5 mRNA in basal layer undi¡erentiated se-
bocytes suggested that the hK activities might be of more impor-
tance in the early di¡erentiation of sebocytes rather than in their
terminal di¡erentiation into the holocrine secretory state. In
eccrine sweat glands, in contrast to KLK1, KLK4, KLK6,
KLK11, and KLK14 mRNAs, which are found in the cytoplasm,
KLK9 and KLK10 as well as SPINK5 mRNA showed dominant
Table III. Comparison of intensities of KLK and SPINK5 mRNAs hybridization in in situ hybridization, normal skin
KLK1 KLK4 KLK6 KLK9 KLK10 KLK11 KLK13 KLK14 SPINK5
Stratum granulosum þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Stratum spinosum þ þ þ  þ þ þ þ þ
Stratum basale þ þ ^ þ   þ þ þ þ
Hair follicles
inner root sheath þ þ þ þ þ þ þ þ þ þ þ þ ^ þ þ þ
outer root sheath þ þ þ  þ þ   þ
Sweat glands
inner lumen þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
outer lumen þ þ þ þ þ þ ^ þ ^ þ þ þ þ þ
Sebaceous glands þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Although the hybridization intensity seemed to be almost identical within each area, measurement was performed at ¢ve di¡erent points to con¢rm the identity. The
hybridization intensities in each area of four individuals were compared using Friedman’s analysis. According to signi¢cant di¡erences, the intensities were categorized in
four groups: , no signi¢cant di¡erence over background staining; þ, less than twice background staining; þ, two to four times background staining; þ þ, more
than four times as high as the background staining.
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expression at the cytoplasm adjacent to the inner lumen, imply-
ing a more active role for production and secretion of sweat than
other KLK mRNAs. KLK13 mRNA may not be considered to
play an important role in the normal function of any appendage.
On the other hand, hK1 has been shown to cleave lipoprotein
and pro-collagenase (Bhoola et al, 1992), and is known to have the
ability to release bioactive kinin, possessing functions of vasodi-
lator and pain-producing autacoids, from a kininogen (Ritten-
house et al, 1998; Yousef and Diamandis, 2001). The mRNA of
low molecular weight kininogen, which is a substrate of hK1,
was not detected in normal skin, but both psoriatic skin and ato-
pic eczema expressed it, along with KLK1 mRNA (Schremmer-
Danninger et al, 1999). hK7 is a potential enzyme of interleukin-1b
(IL-1b) activation by its proteolytic modi¢cation (Nylander-
Lundqvist and Egelrud, 1997) and is reportedly upregulated in
psoriatic lesions (Ekholm and Egelrud, 1999). In addition to the
physiologic role of constitutively expressed hKs in normal skin,
the role of hK1kinin and hK7IL-1b systems in in£ammatory
skin diseases might be taken into account.
Our preliminary investigation also displayed that an increase in
the SC hydrolytic activity in a psoriatic patient was associated
with an increase in some KLK mRNAs (Komatsu et al, 2002b).
As di¡erential expression of various KLK mRNAs coexisted
with SPINK5 mRNA both in the SC and in appendages, it is
attractive to consider that skin serine protease activity is regulated
by hK-SPINK5-derived peptides. As the KLK structure was only
recently identi¢ed, however (Yousef and Diamandis, 2001), not
only the stoichiometric relationship between hKs and SPINK5-
derived peptides but also the biochemical features of each hK are
still unknown. Further quantitative analysis as well as histologic
analysis may help us to understand the signi¢cance of each hK
for the maintenance of maturation, homeostasis, and barrier
function of skin.
We thank patients for generous cooperation, and K. Hama andY. Obata for their help
in preparing ¢gures.
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